- You can view the full Teva Ratings Report.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
We used to think of what's in the public's interest when it comes to securities.
The Swiss pharmaceutical firm's U.S. generic pill business could attract as much as $1.6 billion, Reuters reported.
On Thursday alone, we experience both free-fall, as well as a raucous rally.
The Dow, S&P 500 and Nasdaq all finish higher on Thursday.